Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of the combined parameters including the frequency of primary cilia, PD-L1, Smoothened protein, membranous β-catenin and cytoplasmic β-catenin expression with the outcome of patients with clear cell renal cell carcinoma.
Rozsypalova A, Rosova B, Filipova A, Nikolov DH, Chloupkova R, Richter I, Zachoval R, Matej R, Melichar B, Buchler T, Dvorak J. Rozsypalova A, et al. Among authors: zachoval r. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024 Feb 29. doi: 10.5507/bp.2024.005. Online ahead of print. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2024. PMID: 38420990
Development of an effective predictive screening tool for prostate cancer using the ClarityDX machine learning platform.
Hyndman ME, Paproski RJ, Kinnaird A, Fairey A, Marks L, Pavlovich CP, Fletcher SA, Zachoval R, Adamcova V, Stejskal J, Aprikian A, Wallis CJD, Pink D, Vasquez C, Beatty PH, Lewis JD. Hyndman ME, et al. Among authors: zachoval r. NPJ Digit Med. 2024 Jun 20;7(1):163. doi: 10.1038/s41746-024-01167-9. NPJ Digit Med. 2024. PMID: 38902526 Free PMC article.
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients.
Dietz J, Graf C, Berg CP, Port K, Deterding K, Buggisch P, Peiffer KH, Vermehren J, Dultz G, Geier A, Reiter FP, Bruns T, Schattenberg JM, Durmashkina E, Gustot T, Moreno C, Trauth J, Discher T, Fischer J, Berg T, Kremer AE, Müllhaupt B, Zeuzem S, Sarrazin C; European HCV Resistance Study Group. Dietz J, et al. JHEP Rep. 2024 Mar 25;6(7):101072. doi: 10.1016/j.jhepr.2024.101072. eCollection 2024 Jul. JHEP Rep. 2024. PMID: 39006503 Free PMC article.
Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe.
Vynckier P, Annemans L, Raes S, Amrouch C, Lindgren P, Májek O, Beyer K, Leenen RCA, Venderbos LDF, Denijs F, van Harten MJ, Helleman J, Chloupková R, Briers E, Vasilyeva V, Rivas JG, Basu P, Chandran A, van den Bergh RCN, Collen S, Van Poppel H, Roobol MJ; Members of the PRAISE-U Consortium. Vynckier P, et al. Eur Urol. 2024 Nov;86(5):400-408. doi: 10.1016/j.eururo.2024.04.036. Epub 2024 May 23. Eur Urol. 2024. PMID: 38789306 Free PMC article. Review.
Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium.
Beyer K, Leenen R, Venderbos LDF, Helleman J, Denijs F, Bramer W, Vasilyeva V, Briers E, Rivas JG, Chloupkova R, Majek O, Annemans L, Vynckier P, Basu P, Chandran A, van den Bergh R, Collen S, van Poppel H, Roobol MJ; The PRAISE-U Consortium. Beyer K, et al. J Pers Med. 2024 Jan 11;14(1):84. doi: 10.3390/jpm14010084. J Pers Med. 2024. PMID: 38248785 Free PMC article. Review.
Navigating through the Controversies and Emerging Paradigms in Early Detection of Prostate Cancer: Bridging the Gap from Classic RCTs to Modern Population-Based Pilot Programs.
Gómez Rivas J, Leenen RCA, Venderbos LDF, Helleman J, de la Parra I, Vasilyeva V, Moreno-Sierra J, Basu P, Chandran A, van den Bergh RCN, Collen S, Van Poppel H, Roobol MJ, Beyer K; The PRAISE-U Consortium. Gómez Rivas J, et al. J Pers Med. 2023 Dec 1;13(12):1677. doi: 10.3390/jpm13121677. J Pers Med. 2023. PMID: 38138904 Free PMC article.
Patient-reported outcomes before treatment for localized prostate cancer: are there differences among countries? Data from the True North Global Registry.
Garin O, Kowalski C, Zamora V, Roth R, Ferrer M, Breidenbach C, Pont A, Belin TR, Elashoff D, Wilhalme H, Nguyen AV, Kwan L, Pearman EK, Bolagani A, Sampurno F, Papa N, Moore C, Millar J, Connor SE, Villanti P, Litwin MS; True North Global Registry. Garin O, et al. BMC Urol. 2023 Nov 3;23(1):178. doi: 10.1186/s12894-023-01344-0. BMC Urol. 2023. PMID: 37919726 Free PMC article.
219 results